Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • UNH vs GSK✓SelectedUSD · GSKUNH vs GSK performance historyLatest closeAs of+1.12%11/16
Stock and ETF performance explorer

UNH vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+221.2%
GSK return
+107.3%
Excess return
+114.0%
Maximum drawdown
-61.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.1%-0.1%+1.2%+1.2%
7D+3.6%-1.3%+4.9%+4.2%
30D+2.6%+2.7%-0.1%+1.5%
3M+3.2%+2.7%+0.5%+1.8%
6M+5.9%+3.3%+2.5%+3.8%
YTD+27.3%+6.5%+20.8%+21.7%
1Y+31.4%+10.7%+20.8%+23.5%
3Y-18.7%+64.4%-83.1%-39.1%
5Y+0.3%+46.7%-46.4%-21.7%
10Y+221.2%+109.4%+111.9%+111.3%
All+221.2%+107.3%+114.0%+111.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling